Such marker could be TP53, the most common mutated gene in high‐grade serous ovarian cancer [1], however, because there are no hotspot mutations in TP53 or any other known gene in ovarian cancer, a control marker for liquid biopsy may be challenging. Here, TP53 is linked to ovarian cancer.